Barcelona-based Gate2Brain secures €7 million to advance brain tumour candidate
Barcelona-based Gate2Brain, a promising BioTech company, has secured €7 million in its largest investment round to date. This significant funding will advance their therapeutic candidate for aggressive brain tumours, signalling continued investor confidence in European oncology innovation. The strategic partnership with Shilpa Biocare Pvt Ltd, a subsidiary of Shilpa Medicare Limited, further bolsters Gate2Brain's mission to tackle critical unmet medical needs. The investment positions Gate2Brain within a dynamic European BioTech funding landscape, characterized by substantial capital flow into oncology, CNS-related delivery, and advanced therapeutic modalities. While this round is smaller than later-stage financings, it aligns with earlier-stage therapeutic platform investments like iDEL Therapeutics' €9 million Seed round and Kupando's €10 million Series A. The Spanish HealthTech sector, including companies like Biorce, is witnessing active domestic development, though Gate2Brain's focus remains sharply on therapeutic solutions for brain tumours and CNS diseases. Gate2Brain, a 2020 spin-off from prominent Barcelona institutions, leverages its proprietary technology for blood-brain barrier delivery. This innovation is crucial for treating difficult-to-reach brain tumours and other central nervous system disorders, highlighting the EU's drive towards specialized, high-impact digital health solutions. The company's progress underscores the growing European capacity in cutting-edge biomedical research and development.
Curated and translated by Europe Digital for our multilingual European audience.
Why this matters for European digital sovereignty
Barcelona-based Gate2Brain's €7 million funding round highlights investor confidence in European oncology innovation and specialized therapeutic solutions. This investment supports the advancement of their brain tumour candidate, showcasing the dynamic European BioTech ecosystem and its focus on critical unmet medical needs. The company's proprietary blood-brain barrier delivery technology aligns with the EU's drive for advanced digital health solutions.
Source Information
European Alternatives You Might Like
Mangopay
Mangopay is a payment infrastructure provider specializing in payments for marketplaces and platforms. It offers virtual wallet technology for managing funds, enabling features such as split payments, multi-currency support, and KYC/AML compliance. Key functionalities include automated payouts, transaction monitoring, and customizable payment flows. This service is primarily aimed at businesses that manage marketplaces, crowdfunding platforms, and sharing economy models and require complex payment solutions. Mangopay distinguishes itself by offering a flexible and scalable payment solution specifically designed for platform-based business models, allowing them to control cash flows and streamline payment processes.
Scaleway
Scaleway is a European cloud computing provider offering a range of services, including servers, storage, and networking solutions. Key features include bare metal servers, virtual machines, object storage, and managed Kubernetes. It's suitable for developers, startups, and businesses seeking cloud infrastructure for web applications, data storage, and various other workloads. Scaleway distinguishes itself through competitive pricing and a focus on European data sovereignty, with data centers in France and the Netherlands.